An observational study in Complications of Surgical and Medical Care: General Terms, Adverse Reaction to Drug and Sequelae of External Causes of Morbidity and Mortality, sponsored by Royal College of Anesthesiologists of Thailand. Completed at 9 sites in Thailand. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-03-27.
Sponsored by Royal College of Anesthesiologists of Thailand · Observational
The study observed the 28 days mortality of 9 participated University base surgical intensive care unit (SICU) as well as the occurrence of adverse events in SICU.
The adverse events included pulmonary aspiration, pulmonary emboli, drug error, new stroke, symptomatic deep vein thrombosis, pneumothorax, unplanned extubation, upper GI hemorrhage, myocardial infarction, abdominal hypertension, acute lung injury(ALI)/acute respiratory distress syndrome (ARDS), re-intubation within 72 hours, delirium, cardiac arrest, new arrhythmia, acute kidney injury, sepsis
1,881 studies on the registry are indexed under Critical Illness; 462 are open to participants now.
This study's enrollment of 4,652 is above the median of 130 across 867 observational studies indexed under Critical Illness.
Browse Critical Illness studies →This is the only study on the registry with Royal College of Anesthesiologists of Thailand as lead sponsor.
Counted across the registry records on this site, refreshed daily.
All SICU admission patients
Exclusion Criteria:
All ICU admission to surgical intensive care unit at cohort time
Overall Mortality
Number of Participants who Did Not Survive up to 28 days after surgical ICU admission
Time frame: 28 days
Readmission to ICU
Number of Participants with Readmission to ICU up to 3 days (72 hours) after discharge from ICU
Time frame: 3 days
| Milestone | All ICU Admission Patients |
|---|---|
| Started | 4652 |
| Completed | 4652 |
| Not completed | 0 |
Number of Participants who Did Not Survive up to 28 days after surgical ICU admission
| participants | All ICU Admission Patients |
|---|---|
| Overall Mortality | 642 |
Number of Participants with Readmission to ICU up to 3 days (72 hours) after discharge from ICU
| participants | All ICU Admission Patients |
|---|---|
| Readmission to ICU | 144 |
Collected over Up to 28 days after surgical ICU admission. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Survive at Day 28 | — | 1,070/4,010 (26.7%) | 253/4,010 (6.3%) |
| Non-survive at Day 28 | — | 519/642 (80.8%) | 90/642 (14%) |
| Event | Survive at Day 28 | Non-survive at Day 28 |
|---|---|---|
| SepsisInfections and infestations | 607/4010 | 300/642 |
| Acute kidney injuryRenal and urinary disorders | 491/4010 | 295/642 |
| Cardiac arrestCardiac disorders | 17/4010 | 209/642 |
| Acute lung injury/ Acute respiratory distress syndromeRespiratory, thoracic and mediastinal disorders | 119/4010 | 119/642 |
| New arrhythmiaCardiac disorders | 184/4010 | 103/642 |
| Upper gastrointestinal hemorrhageGastrointestinal disorders | 33/4010 | 22/642 |
| SeizureNervous system disorders | 26/4010 | 19/642 |
| Myocardial infarctionCardiac disorders | 47/4010 | 19/642 |
| Intra-abdominal hypertensionGastrointestinal disorders | 54/4010 | 17/642 |
| New strokeNervous system disorders | 9/4010 | 2/642 |
| Event | Survive at Day 28 | Non-survive at Day 28 |
|---|---|---|
| DeliriumNervous system disorders | 117/4010 | 46/642 |
| Reintubation within 72 hoursRespiratory, thoracic and mediastinal disorders | 112/4010 | 29/642 |
| Unplanned extubationRespiratory, thoracic and mediastinal disorders | 41/4010 | 16/642 |
| PneumothoraxRespiratory, thoracic and mediastinal disorders | 14/4010 | 11/642 |
| Symptomatic deep venous thrombosisVascular disorders | 10/4010 | 4/642 |
| Self reported medication errorSurgical and medical procedures | 7/4010 | 3/642 |
| Pulmonary aspirationRespiratory, thoracic and mediastinal disorders | 2/4010 | 1/642 |
| Age, Continuous(years) | Survive at Day 28 | Non-survive at Day 28 | Total |
|---|---|---|---|
| Mean | 61.4 ± 17.3 | 63.7 ± 17.4 | 61.7 ± 17.3 |
| Sex: Female, Male(Participants) | Survive at Day 28 | Non-survive at Day 28 | Total |
|---|---|---|---|
| Female | 1692 | 231 | 1923 |
| Male | 2318 | 411 | 2729 |
| Race/Ethnicity, Customized(participants) | Survive at Day 28 | Non-survive at Day 28 | Total |
|---|---|---|---|
| Thai | 4010 | 642 | 4652 |
| Region of Enrollment(participants) | Survive at Day 28 | Non-survive at Day 28 | Total |
|---|---|---|---|
| Thailand | 4010 | 642 | 4652 |
Plan to share: Yes — All the data was managed by the the Medical Research Network of the Consortium of Thai Medical Schools (MedResNet)
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.